183 related articles for article (PubMed ID: 17656252)
21. EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.
Shinmura K; Kageyama S; Tao H; Bunai T; Suzuki M; Kamo T; Takamochi K; Suzuki K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Lung Cancer; 2008 Aug; 61(2):163-9. PubMed ID: 18242762
[TBL] [Abstract][Full Text] [Related]
22. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.
Panagopoulos I; Nilsson T; Domanski HA; Isaksson M; Lindblom P; Mertens F; Mandahl N
Int J Cancer; 2006 Mar; 118(5):1181-6. PubMed ID: 16161041
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
[TBL] [Abstract][Full Text] [Related]
24. Identification of anaplastic lymphoma kinase variant translocations using 5'RACE.
Hernández L; Campo E
Methods Mol Med; 2005; 115():295-314. PubMed ID: 15998975
[TBL] [Abstract][Full Text] [Related]
25. Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors.
Preobrazhenskaya EV; Iyevleva AG; Suleymanova AM; Tiurin VI; Mitiushkina NV; Bizin IV; Ivanstov AO; Gorustovich OA; Shelekhova KV; Kachanov DY; Varfolomeeva SR; Roschin VY; Kazakova AN; Litvinov DV; Shamanskaya TV; Savelov NA; Suspitsin EN; Imyanitov EN
Pediatr Blood Cancer; 2020 May; 67(5):e28220. PubMed ID: 32064735
[TBL] [Abstract][Full Text] [Related]
26. [Inflammatory myofibroblastic tumors].
Sirvent N; Coindre JM; Pedeutour F
Ann Pathol; 2002 Dec; 22(6):453-60. PubMed ID: 12594387
[TBL] [Abstract][Full Text] [Related]
27. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
Kelleher FC; McDermott R
Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
[TBL] [Abstract][Full Text] [Related]
28. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K
Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861
[TBL] [Abstract][Full Text] [Related]
29. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.
Gascoyne RD; Lamant L; Martin-Subero JI; Lestou VS; Harris NL; Müller-Hermelink HK; Seymour JF; Campbell LJ; Horsman DE; Auvigne I; Espinos E; Siebert R; Delsol G
Blood; 2003 Oct; 102(7):2568-73. PubMed ID: 12763927
[TBL] [Abstract][Full Text] [Related]
30. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM
Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210
[TBL] [Abstract][Full Text] [Related]
31. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.
Hornick JL; Sholl LM; Dal Cin P; Childress MA; Lovly CM
Mod Pathol; 2015 May; 28(5):732-9. PubMed ID: 25612511
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.
Li J; Yin WH; Takeuchi K; Guan H; Huang YH; Chan JK
Diagn Pathol; 2013 Sep; 8():147. PubMed ID: 24034896
[TBL] [Abstract][Full Text] [Related]
33. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor.
Debelenko LV; Arthur DC; Pack SD; Helman LJ; Schrump DS; Tsokos M
Lab Invest; 2003 Sep; 83(9):1255-65. PubMed ID: 13679433
[TBL] [Abstract][Full Text] [Related]
34. Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma.
Liang X; Meech SJ; Odom LF; Bitter MA; Ryder JW; Hunger SP; Lovell MA; Meltesen L; Wei Q; Williams SA; Hutchinson RN; McGavran L
Am J Clin Pathol; 2004 Apr; 121(4):496-506. PubMed ID: 15080301
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells.
Armstrong F; Duplantier MM; Trempat P; Hieblot C; Lamant L; Espinos E; Racaud-Sultan C; Allouche M; Campo E; Delsol G; Touriol C
Oncogene; 2004 Aug; 23(36):6071-82. PubMed ID: 15208656
[TBL] [Abstract][Full Text] [Related]
36. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24.
Stachurski D; Miron PM; Al-Homsi S; Hutchinson L; Harris NL; Woda B; Wang SA
Hum Pathol; 2007 Jun; 38(6):940-5. PubMed ID: 17509395
[TBL] [Abstract][Full Text] [Related]
38. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
Ladanyi M; Cavalchire G
Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
[TBL] [Abstract][Full Text] [Related]
39. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
[TBL] [Abstract][Full Text] [Related]
40. ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
Van Roosbroeck K; Cools J; Dierickx D; Thomas J; Vandenberghe P; Stul M; Delabie J; De Wolf-Peeters C; Marynen P; Wlodarska I
Haematologica; 2010 Mar; 95(3):509-13. PubMed ID: 20207848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]